Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / American Depository Shares
-
Shares outstanding
-
1,786,081
-
Total 13F shares
-
529,082
-
Share change
-
+125,023
-
Total reported value
-
$3,747,276
-
Price per share
-
$8.64
-
Number of holders
-
12
-
Value change
-
+$1,082,695
-
Number of buys
-
7
-
Number of sells
-
2
Institutional Holders of KAZIA THERAPEUTICS LTD - American Depository Shares (KZIA) as of Q4 2020
As of 31 Dec 2020,
KAZIA THERAPEUTICS LTD - American Depository Shares (KZIA) was held by
12 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
529,082 shares.
The largest 10 holders included
MORGAN STANLEY, Transform Wealth, LLC, Atom Investors LP, RENAISSANCE TECHNOLOGIES LLC, TRUIST FINANCIAL CORP, SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC, SIMPLEX TRADING, LLC, UBS Group AG, WELLS FARGO & COMPANY/MN, and Cutler Group LP.
This page lists
12
institutional shareholders reporting positions in this security
for the Q4 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.